Insider Trading & Ownership - Babler Martin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Babler Martin
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-06-23
Sale
2020-06-25
8:07 pm
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
15,000$61.86$927,889144,072
(Indirect
Direct)
View
2020-03-03
Sale
2020-03-05
5:21 pm
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
15,000$63.47$952,083239,179
(Indirect
Direct)
View
2019-12-17
Sale
2019-12-19
9:06 pm
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
29,500$53.07$1,565,45518,355
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-02
Option Award
2024-05-03
4:01 pm
N/A
2034-05-02
89bio Inc.ETNBBabler Martin
Director
67,700$067,700
(Direct)
View
2023-06-16
Option Award
2023-06-21
4:11 pm
N/A
2033-06-15
Prelude Therapeutics IncPRLDBabler Martin
Director
23,500$023,500
(Direct)
View
2023-06-08
Option Award
2023-06-09
4:24 pm
N/A
2033-06-07
Neoleukin Therapeutics Inc.NLTXBabler Martin
Director
25,000$025,000
(Direct)
View
2022-06-17
Option Award
2022-06-22
4:13 pm
N/A
2032-06-16
Prelude Therapeutics IncPRLDBabler Martin
Director
31,293$031,293
(Direct)
View
2022-05-12
Option Award
2022-05-16
6:22 pm
N/A
2032-05-11
Neoleukin Therapeutics Inc.NLTXBabler Martin
Director
25,000$025,000
(Direct)
View
2021-07-19
Option Award
2021-07-20
8:30 pm
N/A
2031-07-18
Prelude Therapeutics IncPRLDBabler Martin
Director
36,400$036,400
(Direct)
View
2021-05-11
Option Award
2021-05-13
5:36 pm
N/A
2031-05-10
Neoleukin Therapeutics Inc.NLTXBabler Martin
Director
25,000$025,000
(Direct)
View

Ownership
2021-01-06
9:39 pm
N/A
N/A
Omega Alpha SPACOMEGBabler Martin
Director
0$035,000
(Direct)
View
2020-09-28
Equity Swap
2020-09-28
5:07 pm
N/A
N/A
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
58,557$1000
(Direct)
View
2020-09-28
Disposition
2020-09-28
5:07 pm
N/A
2022-12-29
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
1,048,147$00
(Indirect)
View
2020-09-08
Option Award
2020-09-10
4:28 pm
N/A
2030-09-08
Neoleukin Therapeutics Inc.NLTXBabler Martin
Director
50,000$050,000
(Direct)
View
2020-06-23
Exercise
2020-06-25
8:07 pm
N/A
2023-10-23
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
15,000$0144,072
(Direct)
View
2020-06-23
Exercise
2020-06-25
8:07 pm
N/A
N/A
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
15,000$2.9977144,072
(Direct)
View
2020-03-05
Option Award
2020-03-05
5:21 pm
N/A
2030-03-04
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
200,000$0239,179
(Direct)
View
2020-02-10
Gift
2020-03-05
5:21 pm
N/A
N/A
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
1,159$0239,179
(Direct)
View

Ownership
2020-02-14
5:58 pm
N/A
N/A
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
0$072,534
(Indirect)
View
2019-12-27
Ownership
2020-02-14
5:58 pm
N/A
N/A
Principia Biopharma Inc.PRNBBabler Martin
President, CEO
1,500$072,534
(Direct)
View